Analysts/Institutional Investor Meet/Con. Call Updates

SUPRIYA LIFESCIENCE LTD. .. Creating true values that bind global lzealtl, August 10, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir/Madam, Subject: Intimation of Earnings Call for Unaudited Financial Results for quarter ended June 30, 2026. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Friday, August 14, 2026 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter ended June 30, 2026. The invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. The investor presentation shall be shared with the Exchanges separately. Kindly take the information on record. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE Supriya Lifescience Ltd cordially invites you to their Earnings Call to discuss operational and financial performance for Q1 FY27 Friday, 14th August 2026 at 11:00 AM, IST Access Numbers Diamond Pass Registration Link +91 22 6280 1107 Primary Number +91 22 7115 8008 Management Representative: Hongkong: 800 964 448 • Dr. Satish Wagh – Executive Chairman & WTD Singapore: 800 101 2045 Secondary Number • Dr. Saloni Wagh – Managing Director USA: 1866 746 2133 • Mr. Krishna Raghunathan - Chief Financial Officer UK: 0808 101 1573 EY IR -Runjhun Jain -Runjhun.Jain1@in.ey.com/ Sneha Salian -Sneha2.Salian@in.ey.com